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Milk oligosaccharides exert a prebiotic action that contributes to the development
of the infant gut microbiota during lactation. Given that milk oligosaccharides remain
intact after passage through stomach and small intestine, they can potentially influence
the composition of the gut microbiota when ingested as dietary supplements after
weaning. To address the regulatory effects of specific oligosaccharides in colitis
linked to the microbiota composition, we have supplemented interleukin-10 null
(Il10−/−) mice with four fucosylated and sialylated oligosaccharides. We found that
oral supplementation with 2-fucosyllactose significantly decreased the severity of colitis
as displayed by reduced inflammatory marker expression, histological and diarrhea
scores, an increased epithelial integrity and less pronounced colon shortening. Oral
supplementation with 2-fucosyllactose led to a marked expansion of the commensal
Ruminococcus gnavus, which was accompanied by an enhanced cecal concentration
of propionate. Decreased activation of immune cells by R. gnavus was confirmed
by reconstitution of antibiotic-treated Il10−/− mice and by stimulation of dendritic
cells in vitro. This study demonstrates that post-weaning administration of specific
oligosaccharides can shift the composition of the gut microbiota to lessen chronic
inflammation as observed in Il10−/− mice. The expansion of R. gnavus sets a positive
microbial environment at the cost of pro-inflammatory Gram-negative bacteria, thereby
lowering intestinal inflammation.
Keywords: colitis, IBD, milk oligosaccharide, fucose, carbohydrates, microbiota, Lachnospiraceae,
Ruminococcus
INTRODUCTION
The gastrointestinal tract is colonized by a complex ecosystem of microorganisms that are
referred to as the intestinal microbiota (Lynch and Pedersen, 2016). It consists of trillions of
microbes, mainly found in the colon, from hundreds of different species that live in a mutually
beneficial interdependency with the host organism (Eckburg et al., 2005; Xu et al., 2007). Playing
an important role in immune homeostasis, vitamin provision as well as nutrient utilization
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of indigestible components, the intestinal microbiota fulfills
critical physiological roles within the colonized host (Mazmanian
et al., 2005; LeBlanc et al., 2013; Ramakrishna, 2013; Honda
and Littman, 2016). In the gut, energy for bacterial growth
can be derived through processes such as fermentation of
dietary and host carbohydrates (Chassard and Lacroix, 2013).
Bacterial fermentation products, such as the short chain
fatty acids (SCFA) propionate, acetate and especially butyrate
have beneficial effects on host glucose homeostasis, protect
from inflammation and act as important energy sources for
colonocytes (Sun et al., 2017). Furthermore, an established intact
microbial community also protects the host against pathogen
colonization and expansion by competing for nutrients and
space (Gill et al., 2011). In contrast to an intact microbiota,
a destabilized microbial community is referred to as dysbiosis
(Weiss and Hennet, 2017). Several pathological conditions such
as obesity, diabetes and inflammatory bowel disease (IBD)
correlate with dysbiosis (Turnbaugh et al., 2006; Maloy and
Powrie, 2011; Winer et al., 2017). For instance, a reduced
microbial diversity featuring reduced Firmicutes and outgrown
Proteobacteria are typical hallmarks of dysbiosis in IBD
(Swidsinski et al., 2002). Beside other factors including antibiotic
treatment and bacterial toxins, the host diet contributes to
microbial shifts, especially in the initial postnatal colonization
of the gut (Hussey et al., 2011; Zeissig and Blumberg, 2014;
Backhed et al., 2015). Accordingly, nutrients provided by
breast milk, usually the primary diet in the first period
of life, are critical for defining a healthy microbiota by
supporting growth of beneficial bacterial strains (Pannaraj
et al., 2017). Consequently, among the many beneficial effects
that breastfeeding provides for infants, one is to lower the
occurrence of Crohn’s disease or ulcerative colitis later in life
(Xu et al., 2017). Representing a prominent component of breast
milk, oligosaccharides are of particular interest in this regard
(Hennet and Borsig, 2016).
In human breast milk, oligosaccharides represent a
structurally diverse group of about 200 soluble carbohydrates
that sum up to 5–10 g per liter (Zivkovic et al., 2011). The
composition of milk oligosaccharides varies between individual
mothers and over the course of lactation (Coppa et al., 1993;
Marx et al., 2014). To date, the functional significance for this
oligosaccharide diversity is still debated. In sharp contrast to the
essential contribution of breast milk as a source of energy for
the infant, milk oligosaccharides are indigestible to the newborn
(Sela and Mills, 2010). In fact, mammals lack the enzymatic
machinery necessary to release monosaccharides, such as fucose,
N-acetylglucosamine and sialic acid, which are common building
blocks of milk oligosaccharides (Engfer et al., 2000). Instead,
milk oligosaccharides act as prebiotics, used as nutrients by
selected bacterial groups, such as bifidobacteria (Davis et al.,
2016). In addition to their prebiotic effect, milk oligosaccharides
also affect host-microbe interactions, for example by acting as
receptor decoys preventing pathogen binding to host epithelial
cells (Newburg et al., 2005). Moreover, milk oligosaccharides
affect gene expression in intestinal epithelial cells, influencing
their differentiation, survival and surface glycan expression
(Angeloni et al., 2005; Kuntz et al., 2008).
Previous studies have shown that prebiotic polysaccharides
used as food additives, such as galacto-oligosaccharides or
fructo-oligosaccharides of the inulin type, have a beneficial
effect in Crohn’s disease and ulcerative colitis patients (Wilson
and Whelan, 2017). The mechanisms underlying the positive
effect of prebiotic carbohydrates on colitis and the role
of the microbiota in these processes are largely unknown.
Given the beneficial impact of milk oligosaccharides in
newborns, these oligosaccharides may also exert positive
effects on dysbiotic microbiota after lactation (Peterson et al.,
2013). To date, little is known about the impact of milk
oligosaccharides supplemented in children post-weaning
and in adults (Elison et al., 2016). To clarify the role of
naturally occurring oligosaccharides featuring fucosyl- and
sialyl-residues on the course of colitis, we have investigated
the effects of the orally supplemented oligosaccharides 2-
fucosyllactose (2FL), 3-fucosyllactose (3FL), 3-sialyllactose (3SL),
and 6-sialyllactose (6SL) on the course of intestinal inflammation
in interleukin-10 null (Il10−/−) mice after weaning. These
trisaccharides represent the simplest fucosylated and sialylated
carbohydrates that remain uncleaved by host-encoded
carbohydrate hydrolases.
RESULTS
2FL Supplementation Decreased
Inflammation in Il10−/− Mice
The lack of the immunosuppressive effects mediated by
interleukin-10 leads to a progressive enterocolitis related to
the continuous stimulation of the mucosal immune system by
the microbiota (Kuhn et al., 1993). To assess the impact of
naturally occurring prebiotic oligosaccharides on the course and
severity of colitis, weaned wildtype (WT) and Il10−/− mice
were supplemented with oligosaccharides in drinking water
starting at 3 weeks of age for 4 weeks. A concentration of
5 mM of either lactose (Lac), 2FL, 3FL, 3SL, or 6SL was
provided with the drinking water. This concentration was
chosen, because it fails to induce any signs of discomfort such
as soft stool, diarrhea, decreased weight gain and behavioral
changes. Mice may display intolerance symptoms related to
high lactose concentrations after down-regulation of lactase
expression post-weaning (Fang et al., 2006).
The analysis of inflammatory markers, cytokines, and markers
of epithelial integrity in the distal colon of mice after
4 week of oligosaccharide supplementation revealed that one
oligosaccharide, 2FL, led to significantly decreased expression of
the pro-inflammatory markers iNOS, IL-1β and IL-6 (Figure 1).
At the same time, the expression of TGFβ, a factor involved in
wound healing-associated tissue remodeling, as well as occludin,
a tight junction protein associated with epithelial integrity,
were increased in Il10−/− mice after 2FL supplementation. By
contrast, the structurally related oligosaccharide 3FL and the
sialylated oligosaccharide 6SL did not induce any changes in
Il10−/− mice after oral supplementation. The other sialylated
oligosaccharide, 3SL, decreased IL-1β and TNF expression,
while it also decreased expression of occludin (Figure 1).
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FIGURE 1 | Influence of oligosaccharide supplementation on expression of inflammation markers in Il10−/− mice. Il10−/− mice (open circles) were supplemented
with oligosaccharides for 4 weeks. Expression levels of inflammation markers were assessed by qPCR of distal colonic tissue at 7 weeks of age. Expression of the
iNOS, the cytokines IL-1β, IL-6, TGFβ, TNF, and the tight junction protein occludin was determined. β-actin was used for normalization and the sample that
represents median from Lac supplemented WT mice was used as reference sample according to the 11Ct method. Each group consisted of at least six animals
(N = 6–12) from 2 (3SL, 6SL), 3 (3FL), or 4 (Lac, 2FL) independent supplementation experiments. Error bars indicate SD. P-values were determined by one-way
ANOVA with Dunnett Post-test and are indicated by asterisk (∗) if significantly different from control (Lac) condition (p < 0.05).
The same trend was observed in proximal colon tissue of
Il10−/− mice, which showed a lower degree of inflammation
when compared to distal colon (Supplementary Figure S1A).
None of the oligosaccharides tested changed the expression of
inflammation markers in WT colonic tissue (Supplementary
Figure S1B). These data indicated that specific oligosaccharides
influenced the course of intestinal inflammation. Interestingly,
the structurally related fucosylated oligosaccharides 2FL and 3FL
exerted different effects on the expression of marker genes, thus
underlining the importance of the glycosidic linkages for the
biological roles of oligosaccharides.
The anti-inflammatory effect of 2FL supplementation on
colitis in Il10−/− mice was confirmed by measuring the changes
in colon length in oligosaccharide-supplemented WT and
Il10−/− mice. Only 2FL supplementation maintained a normal
colon length in Il10−/− mice, whereas the other oligosaccharides
had no effect on the shortening of the colon occurring through
inflammation (Figure 2A). Similarly, supplementation with 2FL
decreased diarrhea (Figure 2B) and intestinal permeability
(Figure 2C), in line with the observed increased expression of
occludin in 2FL supplemented Il10−/− mice (Figure 1). Mucosal
damage was examined histologically and scored in distal colon
sections of Lac, 2FL, and 3FL supplemented Il10−/− mice.
Whereas Lac and 3FL supplemented animals showed leukocyte
infiltration, lamina propria swelling, cryptitis, goblet cell loss and
epithelial damage, these traits were markedly decreased in 2FL
supplemented mice (Figure 2D). Blind scoring of histological
sections confirmed that supplementation with 2FL, but not
3FL reduced colitis in comparison to control treatment with
Lac (Figure 2E).
Oligosaccharide Supplementation
Affected the Intestinal Microbiota in
Il10−/− Mice
Considering the selective effects of 2FL against related
oligosaccharides, we anticipated a similar variable impact of each
oligosaccharide supplemented on the intestinal microbiota. Shifts
in intestinal microbial community are likely to influence the local
concentrations of bacterial fermentation products, such as SCFAs
(Macfarlane and Macfarlane, 2003). Accordingly, we measured
the cecal levels of SCFAs in oligosaccharide-supplemented WT
and Il10−/− mice. Whereas most of the oligosaccharides did
not change SCFA levels, 2FL supplementation in Il10−/− mice
was paralleled by increased cecal concentrations of acetate,
propionate, and valerate (Figure 3). To further document the
shifts in intestinal microbial composition over the course of 2FL
and 3FL supplementation, fecal pellets were collected on day
0, day 14, and day 28 of supplementation, and bacterial DNA
diversity was assessed by 16S rRNA sequencing. Oligosaccharide
supplementation did not appear to alter microbial species
richness in neither WT nor Il10−/−, as shown by alpha diversity
rarefaction curves (Supplementary Figure S2A). Microbial
diversity was, however, lower in Il10−/− mice when compared to
WT animals, which is in accordance to previous findings (Gong
et al., 2016). Taxonomic evaluation of sequencing data at the
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FIGURE 2 | Signs of decreased colonic inflammation after 2FL supplementation. WT (filled circles) and Il10−/− (open circles) were supplemented with Lac, 2FL, or
3FL for 4 weeks. (A) Colon length and (B) diarrhea scores (Sakai et al., 2013). (C) Intestinal permeability of supplemented Il10−/− and WT mice as determined by
serum FITC-dextran levels after gavage. (D) Representative images of H&E stained colonic tissue sections. Massive leukocyte infiltration sites are indicated by white
arrows. Scale bar = 100 µm. (E) Colitis score of colonic tissue sections. Each group consisted of at least three animals (N = 3–7) from 2 independent
supplementation experiments. Error bars indicate SD, P-values were determined by one-way ANOVA with Dunnett Post-test, and indicated by asterisk (∗) if
significant (p > 0.05).
FIGURE 3 | Oligosaccharide supplementation change short chain fatty acid concentration in cecal fluid. Concentrations of the SCFAs acetate, propionate, butyrate,
and valerate were analyzed in cecal fluids of WT mice (upper row) and Il10−/− mice (lower row) after 4 weeks of oligosaccharide supplementation in drinking water.
Each group consisted of at least three animals (N = 3–7) from 2 (1 for 3FL and 6SL) independent supplementation experiments. Error bars indicate SD, P-values
were determined by one-way ANOVA with Dunnett Post-test and are indicated by asterisk (∗) if significant (p > 0.05).
family level revealed considerable differences in WT vs. Il10−/−
mice (Supplementary Figure S2B), with a higher abundance of
Porphyromonadaceae and a lower abundance of Bacteroidaceae
and Lachnospiraceae in WT animals in comparison to Il10−/−
mice (Supplementary Figure S2C). Notably, some operational
taxonomic units (OTU) that were abundant in WT mice
appeared to be almost completely absent in Il10−/− mice, such
as S24-7, Prevotellaceae, and Desulfovibrionaceae.
Oral supplementation of Il10−/− mice with Lac did not
affect the microbial composition significantly. By contrast,
the ingestion of 2FL and 3FL induced a marked increase in
Lachnospiraceae over 4 weeks of supplementation (Figure 4A).
In 2FL-supplemented Il10−/− mice, the rise in Lachnospiraceae
(from 10.6 ± 5.5% to 37.1 ± 12.1%) was matched by a
pronounced decrease in Bacteroidaceae (from 51.1 ± 8.4%
to 33.0 ± 7.8%). In 3FL-supplemented Il10−/− mice, the
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FIGURE 4 | Shift in microbiota at family level after 2FL supplementation in IL-10−/− mice. Bacterial DNA was isolated from fecal pellets of 2FL, 3FL and Lac control
supplemented mice on day 0 (D0), day 14 (D14), and day 28 (D28) in Il10−/− mice. Bacterial composition of each sample was assessed by 16S rRNA sequencing.
Individual biological samples of one representative supplementation experiment (N = 3) are shown. Each taxa is shown as the percentage of total OTUs within the
sample. Only the bacterial taxa representing at least 1% of total identified sequences are presented. (A) Bacterial families are shown as percentage of total OTUs.
Each individual replicate is shown. (B) Effect of oligosaccharide supplementation on relative levels of B. acidifaciens, B. vulgatus, and R. gnavus. Mean values are
shown, error bars indicate SD. P-values were determined by one-way ANOVA with Dunnett Post-test and are indicated by asterisk (∗) if significant (p > 0.05).
Frontiers in Microbiology | www.frontiersin.org 5 June 2019 | Volume 10 | Article 1385
fmicb-10-01385 June 17, 2019 Time: 17:32 # 6
Grabinger et al. IBD Protection by 2FL Supplementation
increase of Lachnospiraceae was accompanied by a decrease
in Ruminococcaceae, while Bacteroidaceae remained unchanged.
Further OTU assignment revealed that the increment of
Lachnospiraceae in 2FL-supplemented animals was almost
exclusively due to expansion of the species Ruminococcus gnavus
(from 4.0 ± 3.2% to 31.1 ± 8.3%). On the other hand, the
main representants of Bacteroidaceae consisted of Bacteroides
acidifaciens and Bacteroides vulgatus, which decreased during
2FL supplementation from 26.3 ± 5.5% to 16.0 ± 3.4% and
from 12.6 ± 3.5% to 7.4 ± 2.8%, respectively (Figure 4B).
In 3FL-supplemented animals, expansion of R. gnavus (from
2.1± 1.5% to 18.7± 5.2%) also mainly accounted for the increase
in Lachnospiraceae, which, however, yielded in a lower total
abundance of this microbe after D28. In clear contrast to 2FL
treatment, 3FL supplementation showed a tendency to induce
an increase of B. vulgatus from 7.8 ± 4.5% to 15.1 ± 1.8%.
Altogether, these data indicate that oral supplementation of
Il10−/− mice with 2FL and 3FL led to increased abundance of
the Lachnospiraceae R. gnavus especially upon ingestion of 2FL.
To confirm the growth promoting effect of 2FL on
Lachnospiraceae and R. gnavus in particular, microbiota
composition was additionally analyzed by quantitative real-time
PCR in mice that were supplemented for 4 weeks after weaning
with Lac or 2FL. The relative abundance of Bacteroidaceae,
Lachnospiraceae, Prevotellaceae, and Porphyromonadaceae
in fecal samples was determined by using specific primers
for these groups. In line with the data obtained from 16S
rRNA sequencing, the increase of Lachnospiraceae could
be clearly confirmed (Figure 5). At the species level, the
concomitant increase of R. gnavus upon 2FL supplementation
was also evident. The analysis of additional mice, however,
did not confirm the decrease in Bacteroidaceae levels to a
significance threshold.
Growth Promoting Effect of Fucosylated
Oligosaccharides on R. gnavus
The expansion of R. gnavus during supplementation with
fucosylated oligosaccharides likely reflected a growth advantage
conferred by these carbohydrates on that bacterial species.
R. gnavus has been previously shown to efficiently utilize
mucin glycans including the oligosaccharides 2FL and 3FL
as carbon source (Crost et al., 2013). We confirmed the
growth of R. gnavus ATCC 29149 and compared it to the
proliferation of B. acidifaciens JCM 10556 and B. vulgatus ATCC
29327 cultured in minimal medium supplemented with glucose,
fucose, Lac, 2FL, and 3FL as unique carbohydrate sources. The
three bacterial strains had comparable growth kinetics when
glucose was provided as sole nutrient (Figure 6). Whereas
B. vulgatus failed to efficiently utilize the other carbohydrates,
the growth of B. acidifaciens was robust with glucose and Lac,
and moderate with 2FL and 3FL, indicating that B. acidifaciens
expressed α-fucosidase and β-galactosidase enzymes able to
release galactose and glucose as nutrients. B. acidifaciens,
however, only metabolized free fucose inefficiently. R. gnavus
presented the opposite picture with a robust growth in presence
of fucose (Figure 6). The onset of proliferation was delayed to
50 h post-seeding, indicating that growth was probably either
conditional on the selection of mutants with fucose-metabolizing
ability, or the expression of a fucose-utilization operon. 2FL,
but not 3FL, initiated an early proliferation of R. gnavus,
suggesting that the bacteria express a linkage-specific fucosidase
conferring the preferential release of α1–2 linked fucose. This
linkage specificity may be related to the stronger and earlier
expansion of R. gnavus observed in 2FL- vs. 3FL-supplemented
mice (Figure 4B).
Because the growth of pure bacterial strains in vitro does
not reflect the competition for nutrients prevailing in the
gastrointestinal tract, we have assessed the ability of R. gnavus
to repopulate the gut microbiota of Il10−/− mice after antibiotic
treatment. In general, the induction of spontaneous colitis in
Il10−/− mice is strongly associated with the gut microbial
community (Sellon et al., 1998). Treatment of mice with broad
spectrum antibiotics for 7 days drastically reduced the levels
of intestinal bacteria, which readily returned to initial levels a
week after cessation of the treatment (Figure 7A). This antibiotic
treatment decreased intestinal inflammation for at least 14 days
before restoration of the microbiota as assessed by diarrhea
FIGURE 5 | Relative expansion of bacterial taxa after 2FL supplementation. Bacterial DNA was isolated from fecal pellets of 2FL supplemented Il10−/− mice on day
0, 14, and 28. Bacterial composition of each sample was assessed by qPCR analysis. Bacterial taxa at family level (left) and species level (right). To obtain relative
taxa expansion, 16S DNA was used for total bacteria normalization and samples were referenced to mean taxa abundance on a D0 sample that represents the
median according to 11Ct method. Individual data points from 10 biological replicates of 3 independent supplementation experiments (N = 10). P-values were
determined by one-way ANOVA with Dunnett Post-test and are indicated by asterisk (∗) if significant (p > 0.05).
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FIGURE 6 | Mono- and oligosaccharide utilization by bacterial cultures. B. acidifaciens, B. vulgatus, and R. gnavus were cultured in chopped meat medium (CMM)
to a final OD600 of 0.8. Then they were transferred to Hungate tubes with growth-limiting YCFA medium containing 20 mM of fucose (Fuc), glucose (Glc),
2-fucosyllactose (2FL), 3-fucosyllactose (3FL), or 10 mM of lactose (Lac) to an initial OD600 of 0.05. Negative control tubes (CTRL) contained YCFA medium without
any carbohydrate substrate. Growth was monitored until stationary phase was reached. Mean values are shown from triplicates of 2 independent growth
experiments. Error bars represent SD.
FIGURE 7 | Antibiotic treatment and reconstitution of Il10−/− mice. Mice were treated with antibiotics for 7 days and microbiota allowed to re-colonize for 14 days.
(A) Efficacy of antibiotic treatment was assessed by analyzing 16S rRNA copy numbers in DNA isolated from fecal pellets from Il10−/− mice by qPCR using the
11Ct method. (B) + (C) Colon weight/length ratio (B) and diarrhea score (C) were analyzed to determine colitis severity. (D) Inflammatory marker gene expression
after reconstitution of antibiotic-treated Il10−/− mice with different bacterial strains or culture medium (CTRL). β-actin was used for normalization and the sample that
represents median from untreated WT mice was used as reference sample according to the 11Ct method. Biological replicates are shown from 1 (A–C) or 2 (D)
independent experiments (N = 3–6). Error bars indicate SD. P-values were determined by one-way ANOVA with Dunnett Post-test and are indicated by asterisk (∗) if
significant (p > 0.05).
score (Figure 7B) and colon weight/length ratios (Figure 7C).
Antibiotic-treated Il10−/− mice were reconstituted with 109
CFU of either B. acidifaciens, B. vulgatus, or R. gnavus to
determine the effect of these bacterial strains on inflammation.
In case of R. gnavus and B. acidifaciens, reconstitution yielded
a pronounced increase of these bacteria, which was higher than
the initial abundancies of the respective strains in Il10−/− mice.
By contrast, B. vulgatus only expanded marginally after oral
reconstitution (Supplementary Figure S3). The reconstitution of
mice with Bacteroides did not decrease intestinal inflammation
beyond the stage reached by natural recolonization after
antibiotic treatment (Figure 7D). Reconstitution with R. gnavus,
however, further alleviated inflammation as observed by the
reduced expression of the inflammation markers iNOS, TNF and
IL1β in distal colon tissue (Figure 7D). These results indicate that
the expansion of R. gnavus mediated by 2FL supplementation
contributed to decreased colitis in Il10−/− mice.
Differential Activation of Bone
Marrow-Derived Dendritic Cells by
Bacterial Strains
To evaluate the impact of R. gnavus on inflammation and
immune reactions, we have compared the activation of dendritic
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cells mediated R. gnavus, B. acidifaciens, B. vulgatus, and
Escherichia coli. Bone marrow-derived dendritic cells (BMDCs)
from WT mice were incubated with fixed bacteria and cell
activation was assessed by measuring the surface expression
of the activation markers CD40, CD86, and MHC-II, and
by analyzing cytokine profiles. Stimulation of BMDCs with
E. coli and with pure lipopolysaccharide (LPS) strongly activated
BMDC as evidenced by increased expression of the markers
CD40, CD86, and MHC-II (Figure 8A). Stimulation with
B. vulgatus also yielded a strong induction of activation
markers, whereas B. acidifaciens and especially R. gnavus only
yielded a moderate expression of CD40, CD86, and MHC-II
(Figure 8B). The bacteria tested induced different cytokine
responses in BMDCs. As expected, E. coli and LPS elicited
a strong pro-inflammatory cytokine response characterized by
elevated TNF, IL-1β, IFN-γ, IL-9, IL-12, and IL-27 production
(Figure 8C). B. vulgatus also induced a potent pro-inflammatory
cytokine response with elevated TNF, IFN-γ, IL-9, IL-12, and
IL-27. The cytokine responses to B. acidifaciens and R. gnavus
stimulation were more restricted and mitigated. Interestingly,
R. gnavus induced a strong production of IL-17A, probably
originating from T-cells present in the enriched BMDCs
FIGURE 8 | BMDC stimulation by fixed bacteria. Bone marrow cells were isolated from WT mice and in vitro-differentiated into BMDCs and stimulated with PBS (red
histogram), 100 ng/ml LPS (black/gray histogram) or fixed cultures of E. coli (EC), B. acidifaciens (BA), B. vulgatus (BV), or R. gnavus (RG) at a MOI of 10 (blue
histogram). Activation of BMDCs was determined by expression of activation markers or cytokine secretion. (A) Representative histograms of activation marker
expression of CD40, CD86, and MHC-II. (B) Mean fluorescent intensity of activation markers in 3 independent experiments. (C) Cytokine secretion of stimulated
BMDCs. Biological triplicates are shown (N = 3–5) from 3 independent experiments. Error bars indicate ± SD. P-values were determined by one-way ANOVA with
Dunnett Post-test and are indicated by asterisk (∗) if significant (p > 0.05).
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fractions. Although IL-17A production is increased in IBD
(Fujino et al., 2003), the role of this cytokine in the etiology
of the disease is still controversial. Neutralization of IL-17A
was even shown to be ineffective at curing patients with
moderate to severe Crohn’s disease (Hueber et al., 2012).
Surprisingly, only the pro-inflammatory bacteria E. coli and
B. vulgatus elicited the production of IL-10 (Figure 8C),
which is essential in the maintenance of immune homeostasis
in the gut. The low stimulatory effect of R. gnavus on
BMDC is probably related to its surface molecules, which
lacks LPS. The low stimulatory effect of R. gnavus on
immune cells therefore confirms the beneficial impact on
intestinal inflammation achieved through 2FL supplementation
in Il10−/− mice.
DISCUSSION
Whereas monosaccharides are mainly resorbed in the small
intestine, oligosaccharides transit and remain intact down to the
microbe-rich colon. Our study in Il10−/− mice demonstrated
that the oligosaccharide 2FL specifically promoted the expansion
of the Lachnospiraceae R. gnavus, thereby decreasing the
development of colitis in young animals after weaning. By
this means, 2FL could have an onset-delaying effect in
individuals with a colitis-prone predisposition even in the
post-lactation period. This observed effect was definite for
2FL, while sialylated oligosaccharides such as 3SL or 6SL,
and even the structurally similar 3FL failed to induce colitis
protection, indicating that the mechanism involves a high linkage
specificity. The colitis-reducing effect was accompanied by a
shift in the microbiota that involved a significant increase
of Lachnospiraceae. Interestingly, 2FL could also be shown
to induce significant shifts of microbiota in a cohort of
adult human individuals, showing that the impact of the
bacterial community is not limited to early phase of life
and opening new potential therapy options (Elison et al.,
2016). A potential beneficial effect of 2FL was also seen
in a different study using a dextran sulfate sodium model
of colitis. However, the expansion of Lachnospiraceae was
only transient and eventually overtaken by bacteria of the
Barnesiella genus after 6 weeks (Weiss et al., 2014). Apart from
IBD, 2FL supplementation has been shown to be beneficial
in necrotizing enterocolitis models of newborn rats and
pigs. However, this was not observed in combination with
a change in microbiota and needs to be further evaluated
with intervention on human newborns (Autran et al., 2016;
Cilieborg et al., 2016).
Accumulating evidence suggests the involvement of certain
bacterial taxa of the microbiota to pathological conditions,
such as IBD (Zeng et al., 2017). Nevertheless, a substantial
cause-impact relationship of specific bacterial taxa to disease
phenotype is yet unidentified, probably due to the multifactorial
pathological mechanism of IBD. However, bacteria in general
are believed to be a key factor in IBD progression, whereas
their role in the etiology of IBD is open to discussion. The
results of our experiments with mice that were treated with
antibiotics clearly show that microbiota plays a major role in
the progression of colitis in the Il10−/− model. In our study,
the 2FL-mediated reduction of colitis in the Il10−/− model
was accompanied by the outgrowth of R. gnavus. In contrast
to this finding, other studies and meta-analyses revealed an
expansion of R. gnavus to be indicative for several pathological
conditions, such as Crohn’s disease and allergic diseases in
infants (Chua et al., 2018; Sokol et al., 2018). However, these
findings need to be handled with caution because of their
correlative nature. On the one hand, R. gnavus could just
be a bystander as mucus-degrading bacteria, profiting from
mucus changes in inflammatory conditions, such as increased
mucus thickness and upregulation of Muc2 secretion, which
have both been described for Crohn’s disease (Smirnova et al.,
2001; Strugala et al., 2008; Crost et al., 2013). Intriguingly,
R. gnavus abundance was significantly higher in Il10−/− mice
compared to WT animals at steady state as shown in the
present study. On the other hand, taxonomic profiling of
stool samples from IBD patients revealed that blooming of
R. gnavus is accountable to only one specific clade that is
particularly adapted to oxidative stress given by the inflammatory
environment (Hall et al., 2017). Moreover, Lachnospiraceae and
especially R. gnavus were found to be highly frequent in early-life
gut colonization (Sagheddu et al., 2016). Interestingly, a study
showed that in 2-months old breast-fed infants Lachnospiraceae
consisted exclusively of R. gnavus, while a cow’s-milk based
formula resulted in a more diverse Lachnospiraceae community
(Tannock et al., 2013).
While a colitis-protective effect was only seen with 2FL,
outgrowth of R. gnavus was observed in 2FL as well as 3FL
supplemented animals. One mechanism possibly explaining the
anti-inflammatory effect of 2FL against 3FL may be the faster
rate of expansion of R. gnavus and the higher relative abundance
of this bacterium achieved with 2FL. Supplementation of 2FL
might enable R. gnavus to contribute to a microbial environment
that restricts the colonization with bacteria triggering robust
inflammatory responses. By contrast, the slower expansion of
R. gnavus mediated by 3FL was less efficient at dampening the
expansion of other bacterial taxa to the same extent. The SCFA
propionate has been shown to be protective for colonocytes
by alleviating intestinal inflammation through promotion of
regulatory T cell development (Arpaia et al., 2013; Smith et al.,
2013). The increased proprionate production observed in 2FL-
treated mice (see Figure 3) may thus contribute to the overall
protective effects of the oligosaccharide treatment. Submucosal
invasion of bacteria at local sites of epithelial disruption, which
is frequently seen in the Il10−/− model, leads to activation of
immune cells, release of pro-inflammatory cytokines, such as
TNF, IL-6 and IFN-γ and ultimately even to more epithelial
cell damage and increased leukocyte infiltration (Gunther et al.,
2015). We could show that Bacteroidaceae strains, and especially
B. vulgatus, are much more potent in the activation of dendritic
cells and secretion of those cytokines when compared to
R. gnavus. This might be a possible mode of action how 2FL
supplementation and ensuing R. gnavus expansion leads to a
reduction of Bacteroidaceae in the microbial community and
therefore to a dampened inflammation response. A drastic
Frontiers in Microbiology | www.frontiersin.org 9 June 2019 | Volume 10 | Article 1385
fmicb-10-01385 June 17, 2019 Time: 17:32 # 10
Grabinger et al. IBD Protection by 2FL Supplementation
reduction of Bacteroidaceae might also be the mechanism
providing protection against colitis in antibiotic-treated Il10−/−
mice. However, our study failed to provide any direct evidence
for this mechanism given that the reduction of Bacteroides
species such as B. vulgatus did not reach a significant level.
Alternatively, the relative proportion of Bacteroidaceae measured
by 16S rRNA sequencing may not represent changes in absolute
amounts, but indirectly reflect the relative outgrowth of other
bacterial taxa. Apart from that, we cannot exclude that 2FL
also exerts a direct microbiota-independent effect on intestinal
epithelial or submucosal immune cells. Some oligosaccharides
have been shown to alter epithelial and immune cell responses,
leading to differential gene expression that might influence TLR-
mediated activation or tissue healing (Kuntz et al., 2009; He
et al., 2014). However, at least for DCs recent studies have
shown that 2FL lead to no direct modulation of differentiation
or maturation by 2FL (Perdijk et al., 2018). A potential indirect
mechanism for differential immune cell polarization might
include 2FL-mediated R. gnavus outgrowth that resulted in
a selective expression of the cytokine IL-17 in this study.
Taken together, our data suggest that supplementation in the
post-lactation period with the prebiotic 2FL induces a beneficial
microbial community shift in terms of colitis. Hence, it might be
an interesting and promising supplement for diet in IBD patients
in terms of disease progression.
MATERIALS AND METHODS
Mouse Models
All animal experiments conducted in this study were performed
in compliance with the Swiss Animal Protection Ordinance
and approved by the Veterinary Office of the Canton of
Zurich, Switzerland. B6.129P2-Il10tm1Cgn/J mice, termed Il10−/−
throughout this article, were obtained from Jackson Laboratories
and bred on a C57BL/6J background (WT). All mice were
held in light-cycled and climate-controlled housing conditions
in an IVC facility in T2L cages, received laboratory chow diet
(KLIBA extrudat #3436, Provimi Kliba, SA, Switzerland) and
sterilized drinking water ad libitum, if not stated otherwise. For
experimental conditions, 3–4 mice were held in a cage. At the
end of the experiment mice were euthanized using CO2. Animals
were not reused for multiple experiments. Biological material
from the same mouse was subjected to different types of analyses.
Animal Experiments
Il10−/− mice were weaned 21 days after birth and supplemented
with a 5 mM solution of either 2-fucosyllactose (2FL),
3-fucosyllactose (3FL), 3-sialyllactose (3SL), 6-sialyllactose (6SL)
(Glycom A/S, Hørsholm, Denmark) or D-lactose (Sigma-Aldrich,
Buchs, Switzerland) in sterile filtrated water ad libitum for
28 days. For depletion of intestinal microbiota, 4–6 weeks old
mice were supplied with 0.5 g/L vancomycin (AppliChem),
1 g/L ampicillin (VWR), 1 g/L neomycin (Fisher Bioreagents)
and 0.2% aspartame (Sigma) in drinking water for 6 days.
Once per day, mice received intragastric gavage of 250 µL
of a 1 g/L metronidazole (Sigma) solution. After antibiotic
treatment, mice were treated with 10% PEG 3000 solution
(Sigma) in drinking water to flush the remaining bacteria and
antibiotic. Neo-colonization with specific bacterial strains was
done by intragastric gavage of 250 µL containing 109 CFU of the
respective strain in PBS. Fecal pellets were collected to monitor
changes of the microbiota.
Bacterial Cultures
Anaerobic cultures of Ruminococcus gnavus [ATCC 29149,
(Moore et al., 1976)], Bacteroides acidifaciens [JCM 10556,
(Miyamoto and Itoh, 2000)] and Bacteroides vulgatus [ATCC
29327, (Eggerth and Gagnon, 1933)] were expanded in anoxic
chopped meat medium (DSMZ, #78 including hemin and
vitamin K1) in Hungate tubes at 37◦C. To determine single
carbon source substrate utilization, cultures were transferred to
Hungate tubes containing YCFA medium (Duncan et al., 2002)
supplemented with the respective carbon source as indicated and
cultured at 37◦C. Growth was monitored twice a day for at least
5 days by determination of OD600. The E. coli EHV2 strain that
was isolated and characterized previously, was cultured in LB
medium at 37◦C under aerobic conditions (Huang et al., 2015).
Diarrhea Score
The most remarkable changes in individual consistency of feces
are represented in the diarrhea score, assessed in a blinded
manner and modified after Sakai et al. (2013). 0: normal, dry and
solid feces; 1: swollen, moist feces; 2: soft and mucous feces; 3: wet
and shapeless feces; 4: bloody diarrhea.
Trans-Epithelial Integrity
Mice were intragastrically gavaged with 200 µL of a 60 mg/ml
FITC-Dextran (MW 3000-5000; Sigma) solution in ddH2O
90 min prior to euthanasia. Blood serum was collected after
centrifugation at 1500 × g for 15 min. Serum fluorescence
intensity was measured using a multi-detection microplate
reader (Tecan Infinite R© M200 Pro, Switzerland) at an excitation
wavelength of 485 nm and an emission wavelength of 535 nm.
FITC concentration was calculated from a standard curve using
serial dilutions of FITC–dextran.
Histology and Colitis Score
A tissue sample of 2 cm from distal colon was isolated, briefly
washed with PBS, fixed in 10% neutral buffered formalin (Sigma)
for at least 24 h and processed for paraffin embedding and
sectioning. Histopathological analysis to determine colitis scores
was performed on deparaffinized 5 µm Hematoxylin and Eosin
(Sigma) stained tissue sections. Sections were scored individually
by an independent investigator blinded to the type of treatment
as described previously (Steidler et al., 2000).
RNA Isolation and qPCR
Tissue from proximal or distal colon was homogenized with a
Precellys R© 24 tissue homogenizer (Bertin Instruments) and RNA
was isolated using Trizol reagent (Sigma) after manufacturer’s
instructions. Total RNA (1 µg) was reverse transcribed using
High-Capacity cDNA Reverse transcription Kit (Applied
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BioSystemsTM) following manufacturer’s instructions. For
quantitative PCR reactions KAPA SYBR R© Fast (Sigma) Master
mix was used and amplified with a CFX95 TouchTM Real-Time
System with each 50 nM of the following oligonucleotides: iNOS
for: 5′-AGC CTT GCA TCC TCA TTG GG-3′; iNOS rev: 5′-CCT
TTG AGC CCT TTG TGC TG-3′; TNF for: 5′-GGC CTC CCT
CTC ATC AGT TC-3′; TNF rev: 5′-CAC TTG GTG GTT TGC
TAC GAC-3′; IL-1b for: 5′-GCT GGA GAG TGT GGA TCC
CAA G-3′; IL-1b rev: 5′-TGC TGA TGT ACC AGT TGG GG-3′;
IL-6 for: 5′-CAC GGC CTT CCC TAC TTC AC-3′; IL-6 rev:
5′-GCC ATT GCA CAA CTC TTT TCT C-3′; TGFβ for: 5′-TGG
AGC AAC ATG TGG AAC TC-3′; TGFβ rev: 5′-GTC AGC CGG
TTA CCA-3′; Occdn for: 5′-CCC TGA CCA CTA TGA AAC
AG-3′; Occdn rev: 5′-TTG ATC TGA AGT GAT AGG TG-3′.
Cycling conditions were 50 cycles at 95◦C for 10 s and 60◦C for
30 s after an initial denaturation at 95◦C for 3 min. All targets
included an exon-exon junction-spanning oligonucleotide to
reduce genomic DNA amplification. 11ct method was applied
to analyze the relative gene expression with β-actin as an
endogenous normalization reference and a sample representing
the median from lactose treated WT mice used as control sample.
Isolation, Amplification and Sequencing
of Fecal Pellet Bacterial DNA
Bacterial DNA was isolated from fecal pellets using the QIAamp
DNA stool Mini Kit (QIAGEN) in compliance to manufacturer’s
instructions. 20 ng of bacterial DNA were used to amplify the
V3-V4 16S rRNA region, using oligonucleotides with Illumina
adapters sequences: V3F 340-356: 5′-CTT TCC CTA CAC GAC
GCT CTT CCG ATC TCC TAC GGR AGG CAG CAG-3′
and V4R 805-786: 5′-GGA GTT CAG ACG TGT GCT CTT
CCG ATC TGG ACT ACH VGG GTW TCT AAT-3′. Amplicon
sequencing was performed using an Illumina-MiSeq R© system
(Genotoul, France). The bioinformatics pipeline Quantitative
Insight Into Microbial Ecology (QIIME) open source software
package (Versions 1.8.0 and 1.9.0) was used for taxonomic
classification of 16S rRNA gene sequencing (Caporaso et al.,
2010). Raw datasets were processed by merging, trimming,
chimeric reads purging and OTU construction following the
UPARSE pipeline (Edgar, 2013). Assignment of taxonomic units
was done using the Greengenes database (Version 13.8) as a
reference database (DeSantis et al., 2006).
For determination of bacterial taxa by qPCR 50 nM of specific
oligonucleotides were mixed with KAPA SYBR Fast (Sigma)
Master mix and amplified with a CFX95 TouchTM Real-Time
System. Cycling conditions were 50 cycles at 95◦C for 10 s and
60◦C for 30 s after an initial denaturation at 95◦C for 3 min. The
following primers were used: total bacteria 16S for (Eub338F): 5′-
ACT CCT ACG GGA GGC AGC AG-3′; rev (Eub518R): 5′- ATT
ACC GCG GCT GCT GG -3′ (Guo et al., 2008); R. gnavus for: 5′-
CCA ATT ACG GAA AGC TGG AT-3′; rev: 5′-TCT GCT TTC
CAT GTA TCT TCA CA-3′ (Crost et al., 2013); B. acidifaciens
Rec A for: 5′-AAC CTG ATA ACG GTG AGC AGG CG-3′;
rev: 5′-GCT GAC AGC CGA GGT CAA TTT G-3′; B. vulgatus
for: -5′-GGA GGG GAA AGA CTT ATT TTG C-3′; rev: 5′-
TTC CAC CAC TTC TGC CGA C-3′ (Huang et al., 2015).
Lachnospiraceae for: 5′-CGG TAC CTG ACT AAG AAG C-3′;
rev: 5′-AGT TTY ATT CTT GCG AAC G-3′ (Rinttila et al.,
2004); Bacteroidaceae for: 5′-AAG GTC CCC CAC ATT GG-3′;
rev: 5′-GAG CCG CAA ACT TTC ACA A-3′ (Hermann-Bank
et al., 2013); Porphyromonadaceae for: 5′-ACG CGC GAA TCC
CGA AAA CC-3′; rev: 5′- CTT CGT ACG CTC CTT GCG
GTT G-3′ (Ramirez-Farias et al., 2009). The lack of significant
sequence similarity of the selected primers with unrelated
bacterial sequences was confirmed by BLAST analysis. 11ct
method was applied to analyze the relative taxon abundance
with universal bacterial 16S rRNA (Eub338F and Eub518R) as an
endogenous normalization reference and a sample representing
the median of samples from day 0 was used as a control sample.
Quantitative Analysis of Cecal SCFA
Mouse cecal contents were isolated and centrifuged at 4◦C and
8,000 × g for 10 min. SCFA analysis was done by HPLC using a
cation-H refill cartridge (30× 4.6 mm) and an Aminex HPX-87H
column at a flow rate of 0.4 ml.min−1 for 60 min and eluted
with 10 mM sulphuric acid solution. Quantification was done by
detection of refractive index. The concentration was calculated by
integral area comparison with authentic standard solutions.
In vitro Differentiation and Stimulation of
BMDCs
Bone marrow cells were isolated from tibia, femur and ilium
of C57BL/6 WT mice as previously published by Matheu
et al. (2008) with minor modifications. Briefly, red blood cell
lysis was performed by incubation with ammonium-chloride-
potassium lysis buffer (150 mM NH4Cl, 10 mM KHCO3,
0.1 mM EDTA) for 5 min on ice. Isolated bone marrow
cells were cultured and differentiated in Iscove’s Modified
Dulbecco’s Medium (Gibco), with 10% FCS, GlutaMAX R©
supplement (Gibco), antibiotic-antimycotic solution (Gibco),
and 1 mM sodium pyruvate (Gibco). Cells were differentiated
using 30 ng/mL GM-CSF (Peprotech) and 40 ng/mL IL-4
(Peprotech), replated after 6 days and stimulated after 11 days
of isolation. For stimulation, E. coli EHV2, B. acidifaciens,
B. vulgatus, and R. gnavus were fixed in 2% paraformaldehyde
for 15 min at RT, washed with sterile PBS and reconstituted
to a density of 5 × 108 CFU/mL. BMDCs were stimulated
with either LPS (O111:B4; 100 ng/mL) or the respective fixed
bacterial strains with a multiplicity of infection (MOI) of 10.
After 18 h, cells were washed with PBS and harvested by
scraping. Activation of BMDCs was determined by fluorescence-
labeled antibodies (Biolegend): FITC α-mouse MHC-II (clone
M5/114.15.2; #107696); APC α-mouse CD40 (clone 3/23;
#124612); PE α-mouse CD86 (clone GL-1; #105008). Samples
were acquired using a FACSCantoTM II flow cytometer
(BD Biosciences).
BMDC Cytokine Secretion Analysis
Expression and secretion of cytokines after BMDC stimulation
was determined by ProcartaPlexTM Multiplex immunoassay
(Thermo Fisher Scientific) according to manufacturer’s
instructions. Snap-frozen supernatant from BMDCs was
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diluted 1:2 and incubated with bead mixes B (Lot#140144000)
and C (Lot#144194000). Absolute cytokine concentrations were
assessed by a serial dilution of Standard Mix A (Lot#146651101).
Statistical Analysis
All multiple group comparisons were performed using one-way
ANOVA with Dunnett post hoc test to compare all groups to
a control indicated in the respective figure legend. Continuous
variables are shown as± SD and a p-value< 0.05 was considered
significant. Throughout this study, all data points are shown,
without excluding any outliers. All statistical analyses were
performed using GraphPad Prism (Version 5.03).
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